Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ACGN | Aceragen, Inc. | Svp And General Counsel | $158K | Jan 20, 2023 | ||
PRLD | Prelude Therapeutics Inc | CLO, Interim CFO, Corp Sec. | $9.05K | May 14, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|